Introduction Transgender individuals are at risk for HIV. HIV risks are dynamic and there
have been substantial changes in HIV prevention (eg, pre-exposure prophylaxis [PrEP]). It is …

Introduction HIV incidence is high during pregnancy and breastfeeding with HIV acquisition
risk more than doubling during pregnancy and the postpartum period compared to when …

Background Measuring progress towards the Joint United Nations Programme on HIV/AIDS
(UNAIDS) 90–90–90 treatment targets is key to assessing progress towards turning the HIV …

Introduction: Stigma and disclosure concerns have been key barriers to oral pre-exposure
prophylaxis (PrEP) adherence for African adolescent girls and young women (AGYW) in …

Introduction HIV incidence remains high among African adolescent girls and young women
(AGYW). The primary objective of this study is to assess pre‐exposure prophylaxis (PrEP) …

The efficacy of antiretroviral therapy is significantly compromised by medication non-
adherence. Long-acting enteral systems that can ease the burden of daily adherence have …

The effectiveness of HIV pre-exposure prophylaxis (PrEP) hinges on adherence, which has
been restricted by multifaceted barriers. Uptake of PrEP has been impeded by poor access …

When used appropriately, pre-exposure prophylaxis (PrEP) substantially reduces the risk of
HIV acquisition. Early implementation outcomes often suggest poor PrEP adherence and …

Background In high HIV burden settings, maximising the coverage of prevention strategies is
crucial to achieving epidemic control. However, little is known about the reach and effect of …

Introduction Of the two million new HIV infections in adults in 2014, 70% occurred in sub‐
Saharan Africa. Several African countries have already approved guidelines for pre …